Graham Holdings (GHC)
NYSEConsumer DiscretionaryConglomeratesSnapshot 2026-09-04
$1135.89+1.16%
Close 2026-09-04 · 1-day change
NYSEConsumer DiscretionaryConglomeratesSnapshot 2026-09-04
QuarterlyIQ Insights · GHC
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How this business ranks within consumer discretionary on a research-validated quality screen. As of 2026-09-04.
The screen ranks GHC against its sector on four durable signals: share dilution, return on capital, free-cash-flow yield, and FCF margin. Historically the highest-quality names tended toward better typical outcomes and fewer bad years over multi-year holds (strongest at three years, modest at one), and that pattern showed up even before the price moved. It characterizes business quality, not price direction.
Each leg is a sector-relative percentile (higher is better); 4 of 4 legs were available for this name. The composite is built from these four; the raw value follows each percentile for context.
A forward quality tilt, not a price prediction, and context for your own research rather than a recommendation. Not investment advice.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Consumer Discretionary names rated strong grew net income 63% of the time over the next year (vs 50% for the rest of the cohort, n=5213).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Focus on growing revenues in television broadcasting, healthcare, manufacturing, automotive, and other businesses while managing education segment declines.
Stated as a priority in 4 of last 4 quarters. Revenue grew from $1,165.9 million in 2025-Q1 to $1,302.5 million in 2026-Q2, a 7% increase year-over-year for the latest quarter, with full-year 2025 revenue up 3% from 2024. Growth was driven by television broadcasting, healthcare, manufacturing, automotive, and other businesses, partially offset by education declines. The trajectory is delivering consistent revenue growth across divisions.
“Revenue for the second quarter of 2026 was $1,302.5 million, up 7% from $1,215.8 million in the second quarter of 2025.”
“Revenue for the first quarter of 2026 was $1,236.0 million, up 6% from $1,165.9 million in the first quarter of 2025.”
“Revenue for 2025 was $4,911.6 million, up 3% from $4,790.9 million in 2024.”
“Revenue was $1,278.9 million in 2025-Q3, compared to $1,215.8 million in 2025-Q2.”
Expand healthcare segment through acquisition of Covenant Home Health to strengthen home health services in Eastern Pennsylvania.
Stated in 2 of last 2 quarters. The acquisition of Covenant Home Health was announced in 2026-Q1 and contributed to a 22% revenue increase in healthcare in 2026-Q2 compared to 2025-Q2. Operating income in healthcare declined slightly in 2026-Q2 but adjusted operating cash flow remained strong. The acquisition supports growth strategy in healthcare with early positive revenue impact.
“Revenues increased at healthcare, partially offset by declines at other segments.”
Control operating expenses across divisions to improve operating income and adjusted operating cash flow.
Stated in 4 of last 4 quarters. Operating income grew from $47.5 million in 2025-Q1 to $83.6 million in 2026-Q2 (+76%), with adjusted operating cash flow rising from $88.0 million to $119.8 million (+36%) over the same period. Despite some segment variability, overall expense management and income improvement are delivering positive financial results consistent with management's stated priorities.
Continue repurchasing Class B common stock under Board authorization to manage capital allocation and shares outstanding.
Stated in 3 of last 3 quarters. The Company repurchased 110,471 shares for $122.0 million in the first half of 2026, continuing the Board-authorized share repurchase program. The number of shares outstanding declined modestly, reflecting active capital allocation consistent with management's stated priorities.
“Purchased 110,471 shares of Class B common stock at a cost of $122.0 million in first six months of 2026.”
Over the trailing year it converted 0.75x of net income into operating cash flow. Historically, Consumer Discretionary names rated fragile grew net income 40% of the time over the next year (vs 53% for the rest of the cohort, n=3652).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity (low R² over the window).
4 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Consumer Discretionary names rated stable grew net income 47% of the time over the next year (vs 53% for the rest of the cohort, n=1906).
Not investment advice. As of 2026-09-04.
“Graham Healthcare Group acquired Covenant Home Health of Havertown, PA.”
“Operating income of $83.6 million for 2026-Q2, up 15% from $72.8 million in 2025-Q2.”
“Operating income of $57.8 million for 2026-Q1, up from $47.5 million in 2025-Q1.”
“Operating income of $47.6 million in 2025-Q4, down from $72.5 million in 2024-Q4.”
“Operating income of $67.1 million in 2025-Q3, up from prior quarters.”
“Purchased 32,190 shares of Class B common stock at a cost of $34.1 million in first quarter of 2026.”
“Purchased 3,978 shares of Class B common stock at a cost of $3.5 million in 2025.”